SMART Trademark
Trademark Overview
On Thursday, September 23, 2021, a trademark application was filed for SMART with the United States Patent and Trademark Office. The USPTO has given the SMART trademark a serial number of 97041678. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, March 8, 2024. This trademark is owned by Entrada Therapeutics, Inc.. The SMART trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
Pharmaceutical research and development services
General Information
| Serial Number | 97041678 |
| Word Mark | SMART |
| Filing Date | Thursday, September 23, 2021 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Friday, March 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes |
| Goods and Services | Pharmaceutical research and development services |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 25, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 25, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Entrada Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Monday, September 27, 2021 | NEW APPLICATION ENTERED |
| Monday, October 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 25, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 2, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, June 2, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, June 2, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 30, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 30, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 1, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 11, 2023 | SUSPENSION LETTER WRITTEN |
| Saturday, February 11, 2023 | LETTER OF SUSPENSION E-MAILED |
| Saturday, February 11, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, July 24, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, July 24, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, July 24, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, July 24, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, July 24, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 6, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, March 8, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, November 21, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
